Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 8—August 2004


Syphilis in the HIV Era

Sigall Kassutto*Comments to Author  and John P. Doweiko*
Author affiliations: *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Main Article


Selected laboratory results 1 month after therapy for neurosyphilis in HIV-positive patient with neurosyphilisa

Laboratory test Result
Complete blood count
Leukocytes 5,700/μL
Hematocrit 36%
Platelets 295,000/μL
Electrolytes and renal function tests Within normal limits
Liver function tests Within normal limits
Cerebrospinal fluid evaluation
Leukocytes 8 cells/μL
Differential 100% lymphocytes
Erythrocytes 9 cells/μL
Protein 33 mg/dL
Glucose 78 mg/dL
CSF-VDRL negative
HIV-1 testing
ELISA + WB positive
CD4 count 899 cells/μL
Viral load (RT-PCR) 878 copies/mL
Rapid plasma reagin testing
Baseline 1:128
1 month posttreatment 1:32
3 months posttreatment Nonreactive

aCSF-VDRL, cerebrospinal fluid venereal disease research laboratory test; ELISA, enzyme-linked immunosorbent assay; WB, Western blot; RT-PCR, reverse transcription–polymerase chain reaction.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO